Search
for
Sort by
Research 751–780 of 1000+
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
- Titanium Dioxide Nanoparticles: Effects on Development and Male Reproductive System
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
- Hormonal and Genetic Etiology of Male Androgenetic Alopecia
- Lichen planopilaris: Demographic, clinical and histopathological characteristics and treatment outcomes of 25 cases
- Mitochondrial DNA Variation in Human Hair Shafts Influenced by Physical Characteristics: A Massively Parallel Sequencing Analysis
- Beyond Minoxidil: Off-Label Therapies for Male Androgenetic Alopecia—A Systematic Review with Network Meta-Analyses
- Preliminary Effects of Hyperbaric Oxygen Therapy on Hair Follicle Characteristics in Healthy Subjects
- Perifollicular Elastolysis: A Systematic Review of Clinical Characteristics, Histopathology, and Therapeutic Outcomes
- Preliminary Effects of Hyperbaric Oxygen Therapy on Hair Follicle Characteristics in Healthy Subjects
- Beyond Minoxidil: Evidence-Based Off-Label Therapies for Male Androgenetic Alopecia
- Immunogenetic and metabolic risk factors in male androgenetic alopecia: the role of HLA-DRB1 alleles and vitamin D3 deficiency
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- Oral minoxidil 2.5 mg versus 5 mg for treatment of male androgenetic alopecia: a double-blind randomized clinical trial
- Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
- Assessment of cardiovascular risk factors in male androgenetic alopecia: A case control study in a tertiary care hospital of western Odisha
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- A Study of Serum Ferritin and Thyroid-Stimulating Hormone Levels in Male Patients with Androgenetic Alopecia
- Epigenetic mechanism of Gtl2-miRNAs causes the primitive sheep characteristics found in purebred Merino sheep
- Study on the Sexual Attractiveness of Male Beard and Female Long Hair to the Opposite Sex
- Efficacy of Oral Minoxidil in the Treatment of Androgenic Alopecia in Male Patients Presenting at a Tertiary Care Hospital
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: Reproductive aspects
- Dose–Response Effects of Oral Melatonin on Reproductive Parameters in Intact Male Pomeranian Dogs With Alopecia X: A Controlled Study
- Dissecting cellulitis of the scalp in a paediatric male
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- Tracking research trends and hotspots in sperm DNA fragmentation testing for the evaluation of male infertility: a scientometric analysis